Literature DB >> 25023702

EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination.

L Gómez-Maldonado1, M Tiana1, O Roche2, A Prado-Cabrero1, L Jensen3, A Fernandez-Barral1, I Guijarro-Muñoz4, E Favaro5, G Moreno-Bueno1, L Sanz4, J Aragones6, A Harris5, O Volpert7, B Jimenez1, L del Peso2.   

Abstract

The presence of hypoxic regions in solid tumors is an adverse prognostic factor for patient outcome. Here, we show that hypoxia induces the expression of Ephrin-A3 through a novel hypoxia-inducible factor (HIF)-mediated mechanism. In response to hypoxia, the coding EFNA3 mRNA levels remained relatively stable, but HIFs drove the expression of previously unknown long noncoding (lnc) RNAs from EFNA3 locus and these lncRNA caused Ephrin-A3 protein accumulation. Ephrins are cell surface proteins that regulate diverse biological processes by modulating cellular adhesion and repulsion. Mounting evidence implicates deregulated ephrin function in multiple aspects of tumor biology. We demonstrate that sustained expression of both Ephrin-A3 and novel EFNA3 lncRNAs increased the metastatic potential of human breast cancer cells, possibly by increasing the ability of tumor cells to extravasate from the blood vessels into surrounding tissue. In agreement, we found a strong correlation between high EFNA3 expression and shorter metastasis-free survival in breast cancer patients. Taken together, our results suggest that hypoxia could contribute to metastatic spread of breast cancer via HIF-mediated induction of EFNA3 lncRNAs and subsequent Ephrin-A3 protein accumulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023702      PMCID: PMC4722872          DOI: 10.1038/onc.2014.200

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  53 in total

1.  Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes.

Authors:  S Salceda; J Caro
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

2.  Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.

Authors:  Lei Nie; Hsing-Ju Wu; Jung-Mao Hsu; Shih-Shin Chang; Adam M Labaff; Chia-Wei Li; Yan Wang; Jennifer L Hsu; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2012-04-08       Impact factor: 4.060

3.  A microRNA signature of hypoxia.

Authors:  Ritu Kulshreshtha; Manuela Ferracin; Sylwia E Wojcik; Ramiro Garzon; Hansjuerg Alder; Francisco J Agosto-Perez; Ramana Davuluri; Chang-Gong Liu; Carlo M Croce; Massimo Negrini; George A Calin; Mircea Ivan
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  ROCK: a breast cancer functional genomics resource.

Authors:  David Sims; Borisas Bursteinas; Qiong Gao; Ekta Jain; Alan MacKay; Costas Mitsopoulos; Marketa Zvelebil
Journal:  Breast Cancer Res Treat       Date:  2010-06-20       Impact factor: 4.872

Review 6.  The role of ephrins and Eph receptors in cancer.

Authors:  Hanna Surawska; Patrick C Ma; Ravi Salgia
Journal:  Cytokine Growth Factor Rev       Date:  2004-12       Impact factor: 7.638

7.  A gene-expression signature as a predictor of survival in breast cancer.

Authors:  Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

8.  Hypoxia-inducible transcription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin A1.

Authors:  Toshiharu Yamashita; Kinuko Ohneda; Masumi Nagano; Chika Miyoshi; Naomi Kaneko; Yoshihiro Miwa; Masayuki Yamamoto; Osamu Ohneda; Yoshiaki Fujii-Kuriyama
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

9.  Acute Vhl gene inactivation induces cardiac HIF-dependent erythropoietin gene expression.

Authors:  Marta Miró-Murillo; Ainara Elorza; Inés Soro-Arnáiz; Lucas Albacete-Albacete; Angel Ordoñez; Eduardo Balsa; Alicia Vara-Vega; Silvia Vázquez; Esther Fuertes; Carmen Fernández-Criado; Manuel O Landázuri; Julián Aragonés
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

10.  HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.

Authors:  H Zhang; C C L Wong; H Wei; D M Gilkes; P Korangath; P Chaturvedi; L Schito; J Chen; B Krishnamachary; P T Winnard; V Raman; L Zhen; W A Mitzner; S Sukumar; G L Semenza
Journal:  Oncogene       Date:  2011-08-22       Impact factor: 9.867

View more
  43 in total

1.  Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.

Authors:  Yu-Xia Yang; Li Wei; Yan-Ju Zhang; Takahide Hayano; María Del Pilar Piñeiro Pereda; Hirofumi Nakaoka; Qiang Li; Isabel Barragán Mallofret; Yuan-Zhi Lu; Luca Tamagnone; Ituro Inoue; Xiangdong Li; Jian-Yuan Luo; Ke Zheng; Hua You
Journal:  Clin Exp Metastasis       Date:  2018-06-08       Impact factor: 5.150

2.  Different effects of long noncoding RNA NDRG1-OT1 fragments on NDRG1 transcription in breast cancer cells under hypoxia.

Authors:  Ching-Ching Yeh; Jun-Liang Luo; Nam Nhut Phan; Yi-Chun Cheng; Lu-Ping Chow; Mong-Hsun Tsai; Eric Y Chuang; Liang-Chuan Lai
Journal:  RNA Biol       Date:  2018-12-04       Impact factor: 4.652

3.  EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210.

Authors:  Yiyan Qiu; Yang Chen; Tenghui Zeng; Weizhuang Guo; Wenyu Zhou; Xinjian Yang
Journal:  Mol Biol Rep       Date:  2016-01-16       Impact factor: 2.316

4.  Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription.

Authors:  Shi-Jiang Deng; Heng-Yu Chen; Zeng Ye; Shi-Chang Deng; Shuai Zhu; Zhu Zeng; Chi He; Ming-Liang Liu; Kang Huang; Jian-Xin Zhong; Feng-Yu Xu; Qiang Li; Yang Liu; Chun-You Wang; Gang Zhao
Journal:  Oncogene       Date:  2018-07-03       Impact factor: 9.867

Review 5.  Influence of the interaction between long noncoding RNAs and hypoxia on tumorigenesis.

Authors:  Jun Dong; Jiangbing Xu; Xiang Wang; Bilian Jin
Journal:  Tumour Biol       Date:  2015-11-25

Review 6.  Roles of long non-coding RNAs in gastric cancer metastasis.

Authors:  Zi-Guo Yang; Ling Gao; Xiao-Bo Guo; Yu-Long Shi
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 7.  Non-coding RNAs and potential therapeutic targeting in cancer.

Authors:  Shusuke Toden; Timothy J Zumwalt; Ajay Goel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-13       Impact factor: 10.680

8.  LncRNA GAS5 inhibits Invasion and Migration of Lung Cancer through influencing EMT process.

Authors:  Lihuan Zhu; Dongsheng Zhou; Tianxing Guo; Wenshu Chen; Yun Ding; Wujing Li; Yangyun Huang; Jianyuan Huang; Xiaojie Pan
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207

Review 9.  Stressing out over long noncoding RNA.

Authors:  Timothy E Audas; Stephen Lee
Journal:  Biochim Biophys Acta       Date:  2015-07-02

10.  miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia.

Authors:  Marie Besnier; Stefano Gasparino; Rosa Vono; Elena Sangalli; Amanda Facoetti; Valentina Bollati; Laura Cantone; Germana Zaccagnini; Biagina Maimone; Paola Fuschi; Daniel Da Silva; Michele Schiavulli; Sezin Aday; Massimo Caputo; Paolo Madeddu; Costanza Emanueli; Fabio Martelli; Gaia Spinetti
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.